BAXTER INTERNATIONAL INC (BAX)
NYSE • Healthcare
Last close at July 21, 2026 at 20:00 UTC
Fundamentals Charts
About BAXTER INTERNATIONAL INC
Baxter International Inc. trades on the NYSE under BAX and makes a broad range of hospital and clinical-care equipment, therapies, and supplies across the healthcare sector. Its business spans dialysis treatments, IV therapies, infusion systems, surgical technologies, and critical-care products, and it generated $11.2 billion of revenue in FY2025.
Analyst Ratings
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings Calendar
Technical Indicators
BAXTER INTERNATIONAL INC's Technical Indicators Summary
BAX registers a modest buy stance driven by price that is above its 20- and 50-day averages and well clear of the 200-day trend, even though the very short-term average sits overhead. Momentum measures are lukewarm and the ADX points to only moderate trend strength, while ATR shows moderate volatility around current levels. Notably, on-balance-volume signals net selling pressure and a pivot sits above the market, tempering conviction. Technical takeaway: mild buy bias supported by medium/long-term averages but short-term resistance and selling volume limit upside certainty.
| Indicator | Value |
|---|---|
RSI (14) | 54.17 |
Stochastic %K (14, 3, 3) | 61.65 |
CCI (20) | 24.26 |
WPR (14) | -64.31 |
Momentum (10) | -0.51 |
MFI | 69.09 |
MACD Level (12, 26) | 0.68 |
Bollinger Bands | $20.15 - $23.76 |
ATR (14) | $0.81 (3.68%) |
ADX (14) | 21.45 |
OBV | 102,637,478 |
Classic Pivot Point | $22.97 |
Fibonacci Pivot Point | $22.97 |
Simple Moving Averages | $18.91 - $22.45(5 indicators) |
Exponential Moving Averages | $19.97 - $22.33(5 indicators) |
Get premium market insights delivered directly to your inbox.
Today's Snapshot
BAX closed 0.61% above yesterday's close of 22.07. The session finished with relatively light trading in BAX, at 0.58× its average volume. BAX gains as Baxter's core therapies underpin earnings and advance spin-off integration.
Trading Volume
Below 10d avg (5.4M)
3.1M
vs S&P 500 Today
Moderate Underperformance
-0.29%
52-Week Position
Mid-range
47.5%
Updated: July 21, 2026 at 20:06 UTC